Single dose of ketotifen fumarate. 025% vs 2 Weeks of cromolyn sodium 4% for allergic conjunctivitis

Advances in Therapy

Volumn 19, Issue 4, 2002, Pages 185-193

  Greiner, Jack V ^a   Michaelson, Clifford ^b   McWhirter, Cecilia L ^c   Shams, Naveed B K ^c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Novartis Ophthalmics Inc   (United States)

Author keywords

Allergic conjunctivitis; Clinical trial; Cromolyn; Ketotifen

Indexed keywords

CROMOGLYCATE DISODIUM; KETOTIFEN FUMARATE;

ADULT; ALLERGIC CONJUNCTIVITIS; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MAST CELL DEGRANULATION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BINDING; SECRETORY GRANULE; SINGLE BLIND PROCEDURE;

ADULT; AGED; COMPARATIVE STUDY; CONJUNCTIVITIS, ALLERGIC; CROMOLYN SODIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMAN; KETOTIFEN; MALE; MIDDLE AGE; OPHTHALMIC SOLUTIONS; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0036661320     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02848694     Document Type: Article

References (12)

1. Weeke ER. Epidemiology of hay fever and perennial allergic rhinitis. Monogr Allergy. 1987;21:1-20.
2. Abelson, MB, George MA, Garafalo C. Differential diagnosis of ocular disorders. Ann Allergy. 1993;70:95-113.
3. Allansmith MR, Greiner JV, Baird RS. Number of inflammatory cells in normal conjunctiva. Am J Ophthalmol. 1978;86:250-259.
4. Allansmith MR. Immunology of the eye. In: Allansmith MR, ed. The Eye and Immunology. St. Louis: CV Mosby; 1982:99-115.
5. Abelson MB, Chapin MJ. Current and future topical treatments for ocular allergy. Compr Ophthalmol Update. 2000;1:303-320.
6. Collum LMT, Kilmartin DJ. Acute allergic conjunctivitis. In: Abelson MB, ed. Allergic Diseases of the Eye. Philadelphia: WB Saunders; 2000:120-127.
7. Investigator's Brochure - Ketotifen Fumarate Eye Drops. 5th Ed. Duluth, Ga: Novartis Ophthalmics; November 2001.
8. Grant SM, Goa KL, Fitton A, et al. Ketotifen: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs. 1990;40:412-448.
9. Nabe M, Miyagawa H, Agrawal DK, et al. The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc. 1991;12:267-271.
10. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge - A clinical approach to studying allergic conjunctivitis. Ophthalmology. 1990;108:84-88.
11. Allansmith MR, Ross RN. Ocular allergy and mast cell stabilizers. Surv Ophthalmol. 1986;30:229-244.
12. Abelson MB, George MA, Smith LM. Evaluation of. 05% levocabastine versus 4% sodium cromolyn in the allergen challenge model. Ophthalmology. 1995;102:310-316.